If I follow US standards, I will have to shut almost all drug facilities: G N Singh


G N Singh At a time India-made medicines appear to be losing sheen the world over, the country’s top regulator, the Drug Controller General of India (DCGI), is struggling to ensure quality of drugs in the domestic market. Faced with criticism on many fronts, DCGI feels the India market might not be ready to follow global standards and the Indian industry might even collapse with the stringent norms followed elsewhere.

Talking specifically on Ranbaxy, Drug Controller General G N Singh tells Sushmi Dey the DCGI can become the toughest watchdog when it comes to quality and even ban the company from the India market if it fails further in compliance. Edited excerpts: Read More

Source: http://www.business-standard.com

Advertisements

Tagged as: , , , , , , , , , , , , , , , , , , , , , , , ,

Categorised in: Pharma & Healthcare, Sector News

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: